Last $27.72 USD
Change Today -0.26 / -0.93%
Volume 33.2K
BABY On Other Exchanges
Symbol
Exchange
NASDAQ GS
Berlin
As of 12:16 PM 08/20/14 All times are local (Market data is delayed by at least 15 minutes).

natus medical inc (BABY) Snapshot

Open
$27.70
Previous Close
$27.98
Day High
$27.89
Day Low
$27.39
52 Week High
07/30/14 - $29.55
52 Week Low
08/30/13 - $12.99
Market Cap
895.7M
Average Volume 10 Days
158.0K
EPS TTM
$1.07
Shares Outstanding
32.3M
EX-Date
--
P/E TM
25.8x
Dividend
--
Dividend Yield
--
Current Stock Chart for NATUS MEDICAL INC (BABY)

Related News

No related news articles were found.

natus medical inc (BABY) Related Businessweek News

No Related Businessweek News Found

natus medical inc (BABY) Details

Natus Medical Incorporated provides newborn care and neurology healthcare products worldwide. It offers healthcare products used for the screening, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, and balance and mobility disorders. The company’s product offerings include computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology; newborn care products, such as hearing screening systems, phototherapy devices for the treatment of newborn jaundice, head-cooling products for the treatment of brain injury in newborns, and incubators to control the newborn’s environment; and software systems for managing and tracking disorders and diseases for public health laboratories. It provides ALGO, ABaer, AuDX, and Echo-Screen newborn hearing screeners; and hearing screening supply products that are used with newborn hearing screening devices. The company also offers diagnostic hearing assessment product lines, which include the Navigator Pro system, the Scout sport portable diagnostic device, and the AuDX PRO; and diagnostic hearing supply products. In addition, it provides monitoring systems, balance and mobility products, newborn brain injury diagnostic products, thermoregulation products, and jaundice management products. Further, the company offers photometers, radiometers, patient warming lamps, neonatal heatshields, pediatric scales, blanket warming cabinets, exam lights, oxygen hoods, restraining boards, and newborn circumstraint; neonatal noise attenuators, phototherapy eye masks, and x-ray shields for reproductive organs; and newborn screening data management products. It serves hospitals, clinics, laboratories, physicians, nurses, audiologists, and governmental agencies. Natus Medical Incorporated was founded in 1987 and is headquartered in San Carlos, California.

943 Employees
Last Reported Date: 03/17/14
Founded in 1987

natus medical inc (BABY) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $500.0K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $350.0K
Vice President and General Manager of Newborn...
Total Annual Compensation: $302.9K
Vice President and General Manager of Neurolo...
Total Annual Compensation: $265.0K
Vice President of Medical Affairs, Quality & ...
Total Annual Compensation: $257.0K
Compensation as of Fiscal Year 2013.

natus medical inc (BABY) Key Developments

Natus Medical Incorporated Announces Unaudited and Consolidated Financial Results for the Second Quarter and Year-To-Date Ended June 30, 2014; Provides Earnings Guidance for the Third Quarter of 2014; Revises Earnings Guidance for the Full Year of 2014

Natus Medical Incorporated announced unaudited and consolidated financial results for the second quarter and year-to-date ended June 30, 2014. For the second quarter, the company reported revenue of $86,325,000 against $82,250,000 reported for the second quarter of 2013. Income from operations was $10,306,000 against $6,158,000 a year ago. Income before tax was $11,101,000 against $5,635,000 a year ago. Net income was $7,742,000 or $0.24 diluted earnings per share against $4,020,000 or $0.13 diluted earnings per share a year ago. Non-GAAP income before provision for income tax was $12,266,000 against $8,899,000 for the same period in the last year. Non-GAAP net income was $8,930,000 or $0.28 diluted earnings per share against $6,390,000 or $0.21 diluted earnings per share for the same period in the last year. Non-GAAP Operating profit $11,471,000 against $9,422,000 for the same period in the last year. In the second quarter, the company generated approximately $14 million in cash from operations. For the year to date, the company reported revenue of $171,948,000 against $168,084,000 reported for the second quarter of 2013. Income from operations was $18,986,000 against $11,017,000 a year ago. Income before tax was $20,093,000 against $10,161,000 a year ago. Net income was $13,992,000 or $0.43 diluted earnings per share against $7,462,000 or $0.24 diluted earnings per share a year ago. Non-GAAP income before provision for income tax was $24,267,000 against $15,543,000 for the same period in the last year. Non-GAAP net income was $17,217,000 or $0.53 diluted earnings per share against $10,947,000 or $0.36 diluted earnings per share for the same period in the last year. Non-GAAP Operating profit $23,160,000 against $16,399,000 for the same period in the last year. For the third quarter of 2014, the company expects revenue of $86 million to $89 million and non-GAAP earnings per share of $0.28 to $0.32. For the full year 2014, the company updated its non-GAAP earnings guidance and now expects to report non-GAAP earnings per share of $1.20 to $1.23, an increase from previous guidance of $1.18 to $1.21. Revenue was increased to $347.5 million to $352.5 million compared to previous guidance of $345.0 million to $350.0 million. The company continues to make full year 2014 non-GAAP operating margin goal of 20%.

Natus Medical Mulls Acquisitions

Natus Medical Inc. (NasdaqGS:BABY) intends to pursue acquisitions. Jim Hawkins, President and Chief Executive Officer of Natus, said, "We currently are not planning to do a significant acquisition in 2014. We believe it is important to show ourselves, shareholders, and the medical community the strong leadership company Natus has become and that we are a consistent, organic growing business. With that said, acquisitions are an important part of our business model and we look to pursue acquisitions in the latter part of 2015."

Natus Medical Inc. to Report Q2, 2014 Results on Jul 23, 2014

Natus Medical Inc. announced that they will report Q2, 2014 results Pre-Market on Jul 23, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BABY:US $27.72 USD -0.26

BABY Competitors

Market data is delayed at least 15 minutes.

Company Last Change
CareFusion Corp $44.92 USD -0.01
NeuroMetrix Inc $1.81 USD +0.03
NuVasive Inc $36.10 USD -0.03
Oxford Instruments PLC 1,210 GBp 0.00
View Industry Companies
 

Industry Analysis

BABY

Industry Average

Valuation BABY Industry Range
Price/Earnings 30.2x
Price/Sales 2.5x
Price/Book 2.7x
Price/Cash Flow 30.7x
TEV/Sales 2.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NATUS MEDICAL INC, please visit www.natus.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.